Hepamerz Tablet is a pharmaceutical formulation containing L-Ornithine L-Aspartate (150 mg) and Pancreatin (100 mg), designed to support hepatic function and improve digestive enzyme activity. L-Ornithine L-Aspartate is an amino acid compound that plays a crucial role in ammonia detoxification by enhancing the urea cycle, thereby reducing elevated blood ammonia levels commonly observed in hepatic encephalopathy and other liver dysfunctions. Pancreatin, a mixture of digestive enzymes including amylase, lipase, and protease, aids in the breakdown of carbohydrates, fats, and proteins, facilitating improved digestion and nutrient absorption. Hepamerz Tablet is indicated for patients with chronic liver diseases such as cirrhosis, hepatitis, and fatty liver disease, where impaired liver function leads to metabolic disturbances and digestive insufficiency. The combined action of L-Ornithine L-Aspartate and Pancreatin helps restore metabolic balance, alleviate symptoms like fatigue and abdominal discomfort, and promote overall liver health. This medication should be used under medical supervision, with dosage adjustments based on clinical response and liver function tests. Contraindications include hypersensitivity to any component and acute pancreatitis. Hepamerz Tablet offers a synergistic approach to managing hepatic insufficiency and associated digestive issues, contributing to improved patient outcomes in hepatic care.